www.interpharma.co.th Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Please be informed
given by the audit committee or any board member. Please be informed for acknowledgement, Sincerely yours, Mr. Wutichai Leenabanchong Chairman
11,922.8 million and Baht 10,793.0 million. Increased by Baht 1,199.8 million or 11.1% from increase in net profit resulting to increase in unappropriated retained earnings. Please be informed accordingly
-Linked Bonds which will also contribute to the development of a new asset class, reduce due diligence cost, and help investors to make informed investment decisions. The ASEAN SLBS were developed based on
more informed, investors should understand key information of mutual funds. In addition, low-cost and rule-based investment strategies such as Strategic Betas have been gaining popularity in many markets
rules, regulations and law, or in case of occurrence of any event which necessarily causes amendment or change of the determination of such dates and time to be made as appropriate. Please be informed
change of the determination of such dates and time to be made as appropriate. Please be informed accordingly. Yours sincerely, -Signature- (Mr. Slib Soongswang) Chief Executive Officer Authorized Signatory
change of the determination of such dates and time to be made as appropriate. Please be informed accordingly. Yours sincerely, -Signature- (Mr. Slib Soongswang) Chief Executive Officer Authorized Signatory
and evaluation expense (11) (8) (15) 32% 75% (48) (45) -5% Gain (loss) from crude and product oil price hedging contract 46 (95) (138) N/A N/A 366 (442) N/A Gain (loss) from foreign currency forward
governance and regulatory requirements for new directors and executives Undertaking continued training and evaluation of employees’ knowledge of compliance with the Code of Conduct and Anti-Corruption Policy